Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cardano Deepens Japan Push With Enterprise Deal

Cardano Deepens Japan Push With Enterprise Deal

DailyCoinDailyCoin2026/10/05 16:24

The Cardano Foundation announced a strategic partnership with Pacific Meta aimed at accelerating blockchain adoption among Japanese companies. The collaboration pairs Cardano’s infrastructure with Pacific Meta’s local market knowledge and enterprise integration experience — a practical setup designed to move projects from pilot talk into live use cases.

What the deal is built to do

In its own framing, the Foundation said the partnership will help Japanese firms “bring real-world blockchain use cases to life.” That is the key distinction.

This is not another abstract ecosystem memorandum. It is positioned as an on-the-ground channel for companies that need both the chain and someone who understands how Japanese enterprises actually buy, integrate, and ship technology.

Pacific Meta’s role is the local bridge: market access, integration support, and the operational layer that often decides whether an enterprise blockchain project stalls or scales. Cardano’s side is the infrastructure and network foundation underneath those deployments.

On The Flipside

  • This partnership does not, by itself, reprice ADA or guarantee immediate transaction volume.
  • But it does add another concrete distribution layer in a market where enterprise credibility counts.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53